Takeda pulls EU ramelteon filing
This article was originally published in Scrip
Executive Summary
Takedahas formally withdrawn the EU approval application for its sleep agent Ramelteon (ramelteon) following a negative opinion from the CHMPearlier this year. It is not clear yet if a resubmission will be made.